Sign in

CIK 0001662579 · Non-accelerated filer<br>Smaller reporting company

C4 Therapeutics, Inc.

Sign in to watch
Ticker
CCCC
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
475617627
Phone
(617) 231-0700
Business address
490 ARSENAL WAY, SUITE 120, WATERTOWN, MA, 02472
  1. S-8 Other Securities Offered to Employees in Benefit Plans
  2. POS AM Other Post-effective Amendment for Registration Statement
  3. 10-K Report Annual Report
  4. POSASR Other POSASR
  5. 8-K Event Results of operations
  6. 4 Grant or award Chief Scientific Officer acquired 26,000 shares (grant or award)
  7. 4 Grant or award Chief Legal Officer acquired 20,000 shares (grant or award)
  8. 4 Grant or award Chief Business Officer acquired 20,000 shares (grant or award)
  9. 4 Grant or award Chief People Officer acquired 20,000 shares (grant or award)
  10. 4 Grant or award Chief Financial Officer acquired 26,000 shares (grant or award)
  11. 4 Grant or award President & CEO acquired 81,600 shares (grant or award)
  12. SC 13G Stake Amended Statement of Ownership
  13. SC 13G/A Stake Amended Statement of Ownership
  14. SC 13G/A Stake Amended Statement of Ownership
  15. 4 Open-market buy Director bought 5,667 shares at $5.60 ($31,735)
  16. SC 13G/A Stake Amended Statement of Ownership
  17. 8-K Event Executive or director change · Regulation FD disclosure
  18. 4 Shares withheld for taxes Chief Medical Officer gave up 1,301 shares (to pay taxes)
  19. 4 Shares withheld for taxes Chief Financial Officer gave up 1,301 shares (to pay taxes)
  20. 4 Shares withheld for taxes Chief Business Officer gave up 1,222 shares (to pay taxes)

Page 16 of 28 · 549 filings